The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...

As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...

PORTLAND, DC, UNITED STATES, October 28, 2024 /EINPresswire / -- Increase in awareness of endometrial ablation techniques played a major role in th ...

AtriCure stock rose more than 16% on news of plans to expand into pulsed field ablation, a tech that could potentially better treat AFib.

Imricor’s work over past 18 years developing the world’s only MRI-compatible devices for cardiac ablation procedures is ...

Medtronic plc added a second U.S. FDA pulsed field ablation (PFA) device approval to its scorecard with the agency’s ...